Fla. Pharmacy Says Obesity Drug Suit Is Preempted By FDCA

By David Minsky · August 16, 2023, 6:18 PM EDT

A Florida pharmacy accused by Novo Nordisk of selling a compounded version of a popular weight loss drug said the pharmaceutical company lacks standing to sue in federal court because it...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

Novo Nordisk Inc. v. Brooksville Pharmaceuticals Inc.

Case Number

Court

Florida Middle

Nature of Suit

Personal Property: Other

Date Filed

July 06, 2023

Recent Articles By David

October 24, 2024
11th Circ. Seeks Bias Test Briefing In Fla. Trans Patients' Suit
October 17, 2024
Feds Drop Marketing Exec's Tricare Fraud Case In Florida
October 10, 2024
Fla. Panel Frees Officials From Suit Alleging Election Meddling
October 08, 2024
$424M Medicare Fraud Suspect Asks NJ Court To Modify Bail
September 20, 2024
Fla. Judge Trims Health Co. Data Breach MDL
September 04, 2024
Medical Cos. Must Provide Doctor Names In Fla. Qui Tam Suit
July 26, 2024
Fla. Top Court Petitioned To Review 'Misleading' Abortion Info
July 24, 2024
Lab Owner Gets 1 Year In Prison In Medicare Bribe Case
July 18, 2024
Florida Urges 11th Circ. To Allow Gender Law Despite Appeal
July 10, 2024
Acquitted Fla. Atty's Bankruptcy Case Converted To Ch. 7